Plain-English translation of NCT07542808 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 3 — Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.
This trial is testing a new treatment called StromaForte, which uses stem cells derived from donor bone marrow, to see if it can reduce knee arthritis pain better than the standard hyaluronic acid (gel) injection that many people currently receive. The study will compare how well these two treatments work and how safe they are in about 140 people with knee osteoarthritis.
Knee arthritis causes pain and limits movement for many people, and current treatments like hyaluronic acid injections don't work well for everyone. Researchers believe that stem cell therapy might offer a better option by helping to repair damaged cartilage and reduce inflammation.
You likely qualify if…
You likely don't qualify if…
If you join this study, you will receive either a StromaForte stem cell injection or a hyaluronic acid gel injection into your knee. The study team will assess your pain and joint function at screening using questionnaires and imaging, and you'll return for follow-up visits to track how well the treatment works over time. The exact duration and number of visits will be explained during enrollment, and you'll need to be able to commit to completing all assessments as outlined in the study plan.
AI-generated summary from trial data · Jun 21, 2026 · Not medical advice
United Arab Emirates